Nuhad K Ibrahim

Professor

  • 9014 Citations
  • 41 h-Index
1986 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nuhad K Ibrahim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1986 2019

Epidermal Growth Factor
Breast Neoplasms
Neutropenia
Thrombocytopenia
Therapeutics
1 Citation (Scopus)

ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

Tripathy, D., Tolaney, S. M., Seidman, A. D., Anders, C. K., Ibrahim, N., Rugo, H. S., Twelves, C., Dieras, V., Müller, V., Tagliaferri, M., Hannah, A. L. & Cortés, J., Jul 2019, In : Future Oncology. 15, 19, p. 2211-2225 15 p.

Research output: Contribution to journalArticle

Open Access
Brain Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Physicians
Topoisomerase I Inhibitors
4 Citations (Scopus)

Combined inhibition of STAT3 and DNA repair in palbociclib-resistant er-positive breast cancer

Kettner, N. M., Vijayaraghavan, S., Durak, M. G., Bui, T., Kohansal, M., Ha, M. J., Liu, B., Rao, X., Wang, J., Yi, M., Carey, J. P. W., Chen, X., Eckols, T. K., Raghavendra, A. S., Ibrahim, N. K., Karuturi, M. S., Watowich, S. S., Sahin, A., Tweardy, D. J., Hunt, K. K. & 2 others, Tripathy, D. & Keyomarsi, K., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3996-4013 18 p.

Research output: Contribution to journalArticle

DNA Repair
Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Breast Neoplasms
Estrogen Receptors

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022

Translational Breast Cancer Research Consortium (TBCRC), Jan 1 2019, (Accepted/In press) In : Clinical breast cancer.

Research output: Contribution to journalArticle

Brain Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Research
Cerebrospinal Fluid
12 Citations (Scopus)

TBCRC 022: A phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases

Freedman, R. A., Gelman, R. S., Anders, C. K., Melisko, M. E., Parsons, H. A., Cropp, A. M., Silvestri, K., Cotter, C. M., Componeschi, K. P., Marte, J. M., Connolly, R. M., Moy, B., Van Poznak, C. H., Blackwell, K. L., Puhalla, S. L., Jankowitz, R. C., Smith, K. L., Ibrahim, N., Moynihan, T. J., O'Sullivan, C. C. & 10 others, Nangia, J., Niravath, P., Tung, N., Pohlmann, P. R., Burns, R., Rimawi, M. F., Krop, I. E., Wolff, A. C., Winer, E. P. & Lin, N. U., Jan 1 2019, In : Journal of Clinical Oncology. 37, 13, p. 1081-1089 9 p.

Research output: Contribution to journalArticle

Open Access
Brain Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Diarrhea
Brain